BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28672948)

  • 1. (-)-Epigallocatechin gallate but not chlorogenic acid upregulates osteoprotegerin synthesis through regulation of bone morphogenetic protein-4 in osteoblasts.
    Fujita K; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Kawabata T; Sakai G; Kuroyanagi G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Exp Ther Med; 2017 Jul; 14(1):417-423. PubMed ID: 28672948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
    Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
    Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification by (-)-epigallocatechin gallate and chlorogenic acid of TNF-α-stimulated interleukin-6 synthesis in osteoblasts.
    Yamamoto N; Tokuda H; Kuroyanagi G; Kainuma S; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    Int J Mol Med; 2015 Dec; 36(6):1707-12. PubMed ID: 26496857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
    Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M suppresses bone morphogenetic protein-4-induced osteoprotegerin synthesis in MC3T3-E1 osteoblast-like cells: p70 S6 kinase attenuation.
    Hioki T; Tachi J; Matsushima-Nishiwaki R; Iida H; Kozawa O; Tokuda H
    Cell Biochem Funct; 2024 Jun; 42(4):e4068. PubMed ID: 38817105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
    Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
    Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine suppresses BMP-4-induced release of osteoprotegerin via inhibition of the SMAD signaling pathway in osteoblasts.
    Tachi J; Onuma T; Yamaguchi S; Kim W; Hioki T; Matsushima-Nishiwaki R; Tanabe K; Tokuda H; Kozawa O; Iida H
    Biochem Cell Biol; 2021 Oct; 99(5):578-586. PubMed ID: 33646885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts.
    Tokuda H; Hatakeyama D; Shibata T; Akamatsu S; Oiso Y; Kozawa O
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1202-9. PubMed ID: 12637256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of IGF-I-induced osteoblast migration by (-)-epigallocatechin gallate through p44/p42 MAP kinase signaling.
    Kawabata T; Tokuda H; Sakai G; Fujita K; Matsushima-Nishiwaki R; Otsuka T; Kozawa O
    Biomed Rep; 2018 Oct; 9(4):318-326. PubMed ID: 30233784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
    Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
    J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity.
    Kawabata T; Otsuka T; Fujita K; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2018 Dec; 42(6):3149-3156. PubMed ID: 30272256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
    Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
    J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts.
    Kozawa O; Matsuno H; Uematsu T
    J Cell Biochem; 2001; 81(3):430-6. PubMed ID: 11255225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts.
    Kozawa O; Hatakeyama D; Uematsu T
    J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
    Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits BMP-4-stimulated VEGF synthesis in osteoblasts: suppression of S6 kinase.
    Kondo A; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Int J Mol Med; 2014 Apr; 33(4):1013-8. PubMed ID: 24435444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase limits BMP-4-stimulated osteocalcin synthesis in osteoblasts: regulation of the p38 MAP kinase pathway.
    Kondo A; Tokuda H; Matsushima-Nishiwaki R; Kuroyanagi G; Yamamoto N; Mizutani J; Kozawa O; Otsuka T
    Life Sci; 2014 Feb; 96(1-2):18-25. PubMed ID: 24368139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.